Literature DB >> 8861035

The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice.

A Macela1, J Stulik, L Hernychova, M Kroca, Z Krocova, H Kovarova.   

Abstract

The impact of Lps gene on the course of immune response against subcutaneous infection of mice with Francisella tularensis live vaccine strain was studied. Production and specificity of antibodies, cytotoxic responses of macrophages and NK-cells, spontaneous production ex vivo of cytokines IL-1 alpha, IL-2, IL-4, IL-6, IL-10, IFN-gamma, and TNF-alpha in spleen cell cultures in C3H/HeJ (Lps(d)) mice in comparison with C3H/HeN (Lps(n)) mice were tested. The value of LD(50) was significantly different in the two strains of mice (8.0 x 10(5) cfu for C3H/HeJ versus 4.61 x 10(3) cfu for C3H/HeJ mice after subcutaneous inoculation). The production of NO(2) is also impaired in C3H/HeJ mice in the early intervals after infection. Thus, the defective Lps gene of C3H/HeJ mice influences both the level of innate resistance of mice to F. tularensis live vaccine strain infection and the process of induction and regulation of immune response against this intracellular bacterial pathogen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861035     DOI: 10.1111/j.1574-695X.1996.tb00243.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  18 in total

1.  Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS.

Authors:  Jannet Katz; Ping Zhang; Michael Martin; Stefanie N Vogel; Suzanne M Michalek
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Quantitative aspects of lipopolysaccharide and cytokine requirements to generate nitric oxide in macrophages from LPS-hyporesponsive (Lps(d)) C3H/HeJ mice.

Authors:  E Kmonícková; Z Zídek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

Authors:  Christopher W Cluff; Jory R Baldridge; Axel G Stöver; Jay T Evans; David A Johnson; Michael J Lacy; Valerie G Clawson; Vonnie M Yorgensen; Craig L Johnson; Mark T Livesay; Robert M Hershberg; David H Persing
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 4.  Subversion of host recognition and defense systems by Francisella spp.

Authors:  Crystal L Jones; Brooke A Napier; Timothy R Sampson; Anna C Llewellyn; Max R Schroeder; David S Weiss
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

5.  Influence of the bcg locus on natural resistance to primary infection with the facultative intracellular bacterium Francisella tularensis in mice.

Authors:  H Kovárová; L Hernychová; M Hajdúch; M Sírová; A Macela
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans.

Authors:  I Smirnova; M T Hamblin; C McBride; B Beutler; A Di Rienzo
Journal:  Genetics       Date:  2001-08       Impact factor: 4.562

7.  Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility.

Authors:  Irina Smirnova; Navjiwan Mann; Annemiek Dols; H H Derkx; Martin L Hibberd; Michael Levin; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

8.  Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway.

Authors:  M G Schwacha; J J Meissler; T K Eisenstein
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).

Authors:  Susan M Twine; Mireille D Petit; Kelly M Fulton; Robert V House; J Wayne Conlan
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

10.  TLR-dependent control of Francisella tularensis infection and host inflammatory responses.

Authors:  Allison L Abplanalp; Ian R Morris; Bijaya K Parida; Judy M Teale; Michael T Berton
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.